dr reddys laboratories

Representational image only. | Photo Credit: Special Arrangement Pharma major Dr. Reddy’s Laboratories is acquiring the U.S. generic prescription product portfolio of Australia’s Mayne Pharma Group for an upfront cash consideration of…

…

…

Portland, OR, Nov. 01, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Chronic Hepatitis B (CHB) Market size was estimated at $4.6 billion in 2021 and is expected to hit $6.1 billion by…

Stocks to Watch Today: The key benchmark indices seem poised to start on a positive note…

Nifty futures on the Singapore Exchange traded 20 points, or 0.12 per cent lower at 16,207.5, signaling that Dalal Street was headed for a positive start on Monday. Here are a dozen stocks which may buzz the most in today's trade: Spandana…

The two-dose Sputnik V vaccine is already part of the national Covid-19 vaccination programme with 12.11 lakh doses administered so far. Dr Reddy’s Laboratories said it was looking at introducing the Sputnik Light Covid-19 vaccine as a…

Indian giants Sun Pharmaceutical Industries, Optimus Pharma, and Dr Reddy’s Laboratories are exploring the possibility of manufacturing the pill, reports suggest. On Wednesday, Pfizer received the US Food & Drug Administration’s…

Recently, Serum Institute of India sought approval for Covishield as a booster dose citing adequate stock and a demand for a booster shot due to the emergence of new variants. Dr Reddy’s Laboratories has sought permission from India’s drug…

DRL gets rights to commercialise proposed trastuzumab biosimilar in select LatAm, S-E Asia markets. Pharma major Dr. Reddy’s Laboratories has entered into a partnership with Prestige BioPharma under which it will get exclusive rights…